Understanding how brain structure influences cancer cell behavior
How the 3D Architecture of the Brain Shapes Cancer Cell Fate Decisions
This study is looking at how the structure of the brain affects the way cancer cells behave in kids with brain tumors, hoping to find new ways to understand and treat these tumors better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11009679 on NIH RePORTER |
What this research studies
This research investigates how the three-dimensional architecture of the brain affects the decisions made by cancer cells, particularly in pediatric brain tumors. By utilizing advanced techniques like single-cell RNA sequencing, the study aims to uncover how the spatial relationships between tumor cells and their surrounding environment influence cell behavior and fate. The researchers will develop unique transcriptional codes to identify cancer stem cells and subtypes in their 3D locations within the brain, which traditional methods fail to capture. This approach could lead to a better understanding of tumor development and potential new treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are children diagnosed with brain tumors, particularly those with pediatric brain neoplasms.
Not a fit: Patients with brain tumors that are not pediatric in nature or those with advanced-stage tumors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for pediatric brain tumors by targeting the specific interactions between cancer cells and their environment.
How similar studies have performed: Other research has shown promise in understanding tumor microenvironments, but this specific approach using 3D architecture and transcriptional codes is relatively novel.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Filbin, Mariella Gruber — Dana-Farber Cancer Inst
- Study coordinator: Filbin, Mariella Gruber
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.